Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 14,457 |
|
|||||
| News | - | ||||||
| Day High | 0.98 | Low High |
|||||
| Day Low | 0.96 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Talphera Inc | TLPH | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.0083 | -0.85% | 0.9715 | 23:00:03 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.96 | 0.96 | 0.98 | 0.9715 | 0.979799 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 162 | 14,457 | US$ 0.9720206 | US$ 14,053 | - | 0.72 - 1.61 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 17:09:01 | 1 | US$ 0.9501 | USD |
Talphera Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 16.46M | 16.97M | - | 651k | -18.4M | -1.08 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Talphera News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TLPH Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.01 | 1.05 | 0.902 | 1.02 | 27,155 | -0.0385 | -3.81% |
| 1 Month | 1.01 | 1.27 | 0.902 | 1.11 | 65,005 | -0.0385 | -3.81% |
| 3 Months | 1.16 | 1.27 | 0.902 | 1.09 | 64,337 | -0.1885 | -16.25% |
| 6 Months | 0.86 | 1.61 | 0.72 | 1.10 | 101,407 | 0.1115 | 12.97% |
| 1 Year | 0.86 | 1.61 | 0.72 | 1.10 | 101,407 | 0.1115 | 12.97% |
| 3 Years | 0.86 | 1.61 | 0.72 | 1.10 | 101,407 | 0.1115 | 12.97% |
| 5 Years | 0.86 | 1.61 | 0.72 | 1.10 | 101,407 | 0.1115 | 12.97% |
Talphera Description
| AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its product portfolio includes DSUVIA and Zalviso for Moderate-to-severe acute pain. The company's products under pipeline are ARX-02 and ARX-03. The majority of its revenue is generated from DSUVIA product sales in the United States. |
